WILDCAT CAPITAL MANAGEMENT, LLC

PrivateCIK: 1582384
Location

NEW YORK, NY

πŸ“‹ What this filing means

WILDCAT CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $204.60M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

7
Positions
$204.60M
Total AUM (reported)
52.82M
Total Shares

Allocation by class

TOTAL AUM$204.60M7 positions
COM$171.41M83.8%
SPONSORED ADS$32.66M16.0%
SHS$535.9K0.3%

Portfolio Concentration

Top 393.3%4–106.7%TOP 10100.0%0%100%
Top 3$190.97M93.3%
4–10$13.63M6.7%

Top 3 weight

93.3%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 52.82M

Sole

Full voting authority

52.82M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:

FRONTIER GROUP HLDGS INC

SOLE
COM
Shares28.06M
TypeSH
Market value$150.13M
73.37%
Sole
28.06M
Shared
0.00
None
0.00

RLX TECHNOLOGY INC

SOLE
SPONSORED ADS
Shares18.05M
TypeSH
Market value$32.66M
15.96%
Sole
18.05M
Shared
0.00
None
0.00

ALLOGENE THERAPEUTICS INC

SOLE
COM
Shares2.92M
TypeSH
Market value$8.18M
4.00%
Sole
2.92M
Shared
0.00
None
0.00

UROGEN PHARMA LTD

SOLE
COM
Shares495.61K
TypeSH
Market value$6.29M
3.08%
Sole
495.61K
Shared
0.00
None
0.00

SKILLZ INC

SOLE
COM
Shares979.85K
TypeSH
Market value$5.51M
2.69%
Sole
979.85K
Shared
0.00
None
0.00

KRONOS BIO INC

SOLE
COM
Shares1.30M
TypeSH
Market value$1.30M
0.63%
Sole
1.30M
Shared
0.00
None
0.00

SILEXION THERAPEUTICS CORP

SOLE
SHS
Shares1.02M
TypeSH
Market value$535.9K
0.26%
Sole
1.02M
Shared
0.00
None
0.00
WILDCAT CAPITAL MANAGEMENT, LLC 13F Holdings β€” 7 Positions | Finecho